Accelerate Diagnostics Inc expected to post a loss of 28  cents a share - Earnings Preview

Accelerate Diagnostics

12/08/2022 22:24

* Accelerate Diagnostics Inc  AXDX.OQ   AXDX.O  is expected
to show a rise in quarterly revenue when it reports  results on
August 15. 
    * The Denver Colorado-based  company is expected to report 
a
7.2% increase in revenue to $3 million from $2.8 million a year
ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Accelerate
Diagnostics
Inc is for a loss of 28 cents per share. For the same quarter
last year, the company reported a loss of 36 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Accelerate
Diagnostics Inc is $1​, below​ its last closing price of $2.15.
​​​

This summary was machine generated August 12 at 21:24 GMT.  All
figures in US dollars  unless otherwise stated